Betamethasone 17-valerate (BioDeep_00000271430)

   


代谢物信息卡片


Betamethasone 17-valerate

化学式: C27H37FO6 (476.2574)
中文名称: 倍他米松 17-戊酸酯, 倍他米松戊酸酯
谱图信息: 最多检出来源 Viridiplantae(plant) 88.51%

分子结构信息

SMILES: CCCCC(=O)OC1(C(=O)CO)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C
InChI: InChI=1S/C27H37FO6/c1-5-6-7-23(33)34-27(22(32)15-29)16(2)12-20-19-9-8-17-13-18(30)10-11-24(17,3)26(19,28)21(31)14-25(20,27)4/h10-11,13,16,19-21,29,31H,5-9,12,14-15H2,1-4H3

描述信息

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids
CONFIDENCE standard compound; INTERNAL_ID 2833
D000893 - Anti-Inflammatory Agents

同义名列表

3 个代谢物同义名

Betamethasone 17-valerate; Betamethasone-17-valerate; Betamethasone valerate



数据库引用编号

10 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Maria Michela Lauriola, Paolo Sena, Antonio De Bitonto, Monica Corazza. Allergic Contact Dermatitis Due to 'Therapeutic Uses' of Tea Tree Oil on the Lips and Toenails. Dermatitis : contact, atopic, occupational, drug. 2021 May; 32(3):e40-e41. doi: 10.1097/der.0000000000000649. [PMID: 33332860]
  • Arisha Mahmood, Vamshi Krishna Rapalli, Tejashree Waghule, Srividya Gorantla, Sunil Kumar Dubey, Ranendra Narayan Saha, Gautam Singhvi. UV spectrophotometric method for simultaneous estimation of betamethasone valerate and tazarotene with absorption factor method: Application for in-vitro and ex-vivo characterization of lipidic nanocarriers for topical delivery. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2020 Jul; 235(?):118310. doi: 10.1016/j.saa.2020.118310. [PMID: 32251894]
  • C J Chen, A Satyanarayan, B J Schlomer. The use of steroid cream for physiologic phimosis in male infants with a history of UTI and normal renal ultrasound is associated with decreased risk of recurrent UTI. Journal of pediatric urology. 2019 Oct; 15(5):472.e1-472.e6. doi: 10.1016/j.jpurol.2019.06.018. [PMID: 31345734]
  • Beathe Sitter. Urinary detection of corticosteroid in topical treatment of skin disease by 19F MRS. Magma (New York, N.Y.). 2019 Feb; 32(1):157-162. doi: 10.1007/s10334-018-00734-y. [PMID: 30610404]
  • Upendra Nagaich, Neha Gulati. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development. Current drug delivery. 2018; 15(5):641-651. doi: 10.2174/1567201814666170918163615. [PMID: 28925874]
  • Sharlene Helene H Chua, Giselle Marie S Tioleco, Carmela Augusta F Dayrit, Winlove P Mojica, Belen L Dofitas, Lorna F Frez. Atorvastatin as adjunctive therapy for chronic plaque type psoriasis versus betamethasone valerate alone: A randomized, double-blind, placebo-controlled trial. Indian journal of dermatology, venereology and leprology. 2017 Jul; 83(4):441-447. doi: 10.4103/ijdvl.ijdvl_425_16. [PMID: 28540870]
  • Ahmed Samir, Nicholas Bodor, Teruko Imai. Identification of esterase involved in the metabolism of two corticosteroid soft drugs. Biochemical pharmacology. 2017 03; 127(?):82-89. doi: 10.1016/j.bcp.2016.12.010. [PMID: 28017774]
  • Gösta Bethke, Gudrun Bethke, Matthias Prager, Peter Purucker. Title Not Available. Swiss dental journal. 2017 ; 127(6):523-537. doi: NULL. [PMID: 28639684]
  • M Corazza, A Virgili, S Minghetti, G Toni, A Borghi. Dermoscopy in plasma cell balanitis: its usefulness in diagnosis and follow-up. Journal of the European Academy of Dermatology and Venereology : JEADV. 2016 Jan; 30(1):182-4. doi: 10.1111/jdv.12692. [PMID: 25176141]
  • L B Jensen, K Petersson, H M Nielsen. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2011 Sep; 79(1):68-75. doi: 10.1016/j.ejpb.2011.05.012. [PMID: 21664463]
  • R F Castillo, G A Cañadas-De la Fuente, H Husein-Elahmed, J Cantero-Hinojosa. Pyoderma gangrenosum developing over an arteriovenous fistula scar. Internal medicine journal. 2011 May; 41(5):436-7. doi: 10.1111/j.1445-5994.2011.02479.x. [PMID: 21605298]
  • Jin Zhang, Eric Smith. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. Journal of pharmaceutical sciences. 2011 Mar; 100(3):896-903. doi: 10.1002/jps.22329. [PMID: 20839362]
  • P Schlupp, T Blaschke, K D Kramer, H-D Höltje, W Mehnert, M Schäfer-Korting. Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids. Skin pharmacology and physiology. 2011; 24(4):199-209. doi: 10.1159/000324053. [PMID: 21346400]
  • Louise B Jensen, Emily Magnussson, Linda Gunnarsson, Charlotte Vermehren, Hanne M Nielsen, Karsten Petersson. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. International journal of pharmaceutics. 2010 May; 390(1):53-60. doi: 10.1016/j.ijpharm.2009.10.022. [PMID: 19836439]
  • Emmanuel Laffitte, Jean-Pierre Venetz, John-David Aubert, Michel A Duchosal, Renato G Panizzon, Manuel Pascual. Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation. Dermatology (Basel, Switzerland). 2008; 217(1):87-8. doi: 10.1159/000128283. [PMID: 18446031]
  • Narong Sarisuta, Sarinnate Kunastitchai, Lars Pichert, Bernd W Müller. Drug solubility in phospholipid carrier as a predictive parameter for drug recovery in microparticles produced by the aerosol solvent extraction system (ASES) process. Drug development and industrial pharmacy. 2007 Sep; 33(9):932-44. doi: 10.1080/03639040601128670. [PMID: 17891579]
  • L Simonsen, A Fullerton. Development of an in vitro skin permeation model simulating atopic dermatitis skin for the evaluation of dermatological products. Skin pharmacology and physiology. 2007; 20(5):230-6. doi: 10.1159/000104421. [PMID: 17587887]
  • Finn Schultz Larsen, Lene Simonsen, Anita Melgaard, Katja Wendicke, Anne S Henriksen. An efficient new formulation of fusidic acid and betamethasone 17-valerate (fucicort lipid cream) for treatment of clinically infected atopic dermatitis. Acta dermato-venereologica. 2007; 87(1):62-8. doi: 10.2340/00015555-0174. [PMID: 17225018]
  • Iqbal A Bukhari. Solitary mastocytoma successfully treated with a moderate potency topical steroid. Journal of drugs in dermatology : JDD. 2004 May; 3(3):309-10. doi: NULL. [PMID: 15176167]
  • C Ozdemir, L A Schneider, R Hinrichs, G Staib, L Weber, J M Weiss, K Scharffetter-Kochanek. [Allergic contact dermatitis to common ivy (Hedera helix L.)]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2003 Oct; 54(10):966-9. doi: 10.1007/s00105-003-0584-4. [PMID: 14513244]
  • T Leivo, P Arjomaa, J Oivula, M Vesterinen, U Kiistala, P Autio, A Oikarinen. Differential modulation of transforming growth factor-beta by betamethasone-17- valerate and isotretinoin: corticosteroid decreases and isotretinoin increases the level of transforming growth factor-beta in suction blister fluid. Skin pharmacology and applied skin physiology. 2000 May; 13(3-4):150-6. doi: 10.1159/000029920. [PMID: 10859533]
  • H S Zackheim, M Kashani-Sabet, S Amin. Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Archives of dermatology. 1998 Aug; 134(8):949-54. doi: 10.1001/archderm.134.8.949. [PMID: 9722724]
  • L Molin, T P Cutler, I Helander, B Nyfors, N Downes. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group. The British journal of dermatology. 1997 Jan; 136(1):89-93. doi: NULL. [PMID: 9039301]
  • P Andersen, K Kubota, E S Lo, G Huttinot, H Maibach. A time correlation study between reflectance spectroscopic cutaneous vasoconstriction and plasma corticosteroid concentration. The British journal of dermatology. 1995 Jan; 132(1):59-65. doi: 10.1111/j.1365-2133.1995.tb08625.x. [PMID: 7756152]
  • A Ahluwalia, R W Mohamed, R J Flower. Induction of lipocortin 1 by topical steroid in rat skin. Biochemical pharmacology. 1994 Oct; 48(8):1647-54. doi: 10.1016/0006-2952(94)90210-0. [PMID: 7980630]
  • K Kubota, E S Lo, G Huttinot, P H Andersen, H I Maibach. Plasma concentrations of betamethasone after topical application of betamethasone 17-valerate: comparison with oral administration. British journal of clinical pharmacology. 1994 Jan; 37(1):86-8. doi: 10.1111/j.1365-2125.1994.tb04246.x. [PMID: 8148226]
  • A Kecskés, P Jahn, H Matthes, R K Kuhlmann, L Lange. Systemic effects of topically applied methylprednisolone aceponate in healthy volunteers. Journal of the American Academy of Dermatology. 1993 May; 28(5 Pt 1):789-92. doi: 10.1016/s0190-9622(09)80276-4. [PMID: 8496431]
  • K Kragballe, B T Gjertsen, D De Hoop, T Karlsmark, P C van de Kerkhof, O Larkö, C Nieboer, J Roed-Petersen, A Strand, G Tikjøb. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet (London, England). 1991 Jan; 337(8735):193-6. doi: 10.1016/0140-6736(91)92157-w. [PMID: 1670840]
  • G B Colver, J A Symons, G W Duff. Soluble interleukin 2 receptor in atopic eczema. BMJ (Clinical research ed.). 1989 May; 298(6685):1426-8. doi: 10.1136/bmj.298.6685.1426. [PMID: 2568868]
  • A Thalén, R Brattsand, P H Andersson. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects. Acta dermato-venereologica. Supplementum. 1989; 151(?):11-9; discussion 47. doi: . [PMID: 2624062]
  • A D Ormerod, J How, P D Bewsher, I W Reid. Effects of widespread dermatitis and topical steroid therapy on thyroid function tests. Dermatologica. 1988; 176(5):257-9. doi: 10.1159/000248715. [PMID: 3384150]
  • R D Zenoble, R J Kemppainen. Adrenocortical suppression by topically applied corticosteroids in healthy dogs. Journal of the American Veterinary Medical Association. 1987 Sep; 191(6):685-8. doi: . [PMID: 2824410]
  • F Schröpl. [Clinical studies with prednicarbate with special reference to double-blind comparisons with common therapeutic preparations]. Zeitschrift fur Hautkrankheiten. 1986; 61 Suppl 1(?):80-7. doi: NULL. [PMID: 3705676]
  • L Salde, A Lassus. Systemic side-effects of three topical steroids in diseased skin. Current medical research and opinion. 1983; 8(7):475-80. doi: 10.1185/03007998309109785. [PMID: 6226490]
  • S Otomo, S Higuchi, S Nakaike, K Takeshita, M Tanaka, Y Gotoh, Y Osada, K Tsuchida, K Inoue, K Kyogoku, Y Tarumoto, M Sasajima, M Ohzeki. [Pharmacological study on hydrocortisone 17-butyrate 21-propionate (author's transl)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 1981 Dec; 78(6):647-58. doi: 10.1254/fpj.78.647. [PMID: 7333567]
  • R Lipitz, E Tur, S Brenner, A Krakowski. Norwegian scabies following topical corticosteroid therapy. Israel journal of medical sciences. 1981 Dec; 17(12):1165-8. doi: NULL. [PMID: 7327916]
  • R C Cornell, R B Stoughton. Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis. The British journal of dermatology. 1981 Jul; 105(1):91-5. doi: 10.1111/j.1365-2133.1981.tb00888.x. [PMID: 7259982]
  • Y Tarumoto, M Kimura, S Abe, A Kasai, K Noda, S Nakane, M Sasajima, M Ohzeki. [Studies on toxicity of hydrocortisone 17-butyrate 21-propionate -2. Subacute toxicity in rats by subcutaneous administration (author's transl)]. The Journal of toxicological sciences. 1981 Jul; 6 Suppl(?):17-46. doi: 10.2131/jts.6.supplement_17. [PMID: 7310932]
  • P A Bromley, F O Müller, J Malan, J Torres, O Vanderbeke. Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 1978 Aug; 54(6):239-41. doi: NULL. [PMID: 362568]
  • E C Gomez, L Kaminester, P Frost. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies. Archives of dermatology. 1977 Sep; 113(9):1196-202. doi: NULL. [PMID: 332089]
  • D D Munro. The effect of percutaneously absorbed steroids on hypothalamic--pituitary--adrenal function after intensive use in in-patients. The British journal of dermatology. 1976 Mar; 94 suppl 12(?):67-76. doi: 10.1111/j.1365-2133.1976.tb02272.x. [PMID: 1268079]
  • V U Täuber, M Amin, P Fuchs, U Speck. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide]. Arzneimittel-Forschung. 1976; 26(7b):1492-5. doi: NULL. [PMID: 1036945]
  • D D Munro. Topical corticosteroid therapy and its effect on the hypothalamic-pituitary-adrenal axis. Dermatologica. 1976; 152 Suppl 1(?):173-80. doi: 10.1159/000257888. [PMID: 782954]
  • H Wendt, R Reckers. [Systemic effect of diflucortolone valerate after dermal application (author's transl)]. Arzneimittel-Forschung. 1976; 26(7b):1509-13. doi: NULL. [PMID: 188429]
  • C G Sparkes. Plasma cortisol levels in normal subjects after inhaled corticosteroids. Postgraduate medical journal. 1974 Sep; 50 suppl 4(?):9-11. doi: NULL. [PMID: 4467157]